Bibliography

Found 1052 results

2021

Guzman VA, Cham H, Gutierrez J, Byrd D, Morris EP, Tureson K, Morgello S, Mindt MRivera. The Longitudinal Effects of Blood Pressure and Hypertension on Neurocognitive Performance in People Living with HIV. J Acquir Immune Defic Syndr. 2021 .

Lorenz DR, Mukerji SS, Misra V, Uno H, Gelman BB, Moore DJ, Singer EJ, Morgello S, Gabuzda D. Multimorbidity networks associated with frailty among middle aged and older people with HIV. AIDS. 2021 .

Naveed Z, Fox HS, Wichman CS, Alam M, May P, Arcari CM, Meza J, Totusek S, Baccaglini L. Neurocognitive status and risk of mortality among people living with human immunodeficiency virus: an 18-year retrospective cohort study. Sci Rep. 2021 ;11(1):3738.

Pizzirusso M, Carrion-Park C, Clark US, Gonzalez J, Byrd D, Morgello S. Physical and Mental Health Screening in a New York City HIV Cohort During the COVID-19 Pandemic: A Preliminary Report. J Acquir Immune Defic Syndr. 2021 ;86(3):e54-e60.

Sundermann EE, Fields A, Saloner R, Gouaux B, Bharti A, Murphy C, Moore DJ. The utility of olfactory function in distinguishing early-stage Alzheimer's disease from HIV-associated neurocognitive disorders. AIDS. 2021 ;35(3):429-437.

2020

Devanathan AS, Fallon JK, White NR, Schauer AP, Van Horne B, Blake K, Sykes C, Kovarova M, Adamson L, Remling-Mulder L, et al. Antiretroviral Penetration and Drug Transporter Concentrations in the Spleens of Three Preclinical Animal Models and Humans. Antimicrob Agents Chemother. 2020 ;64(10).

May PE, Heithoff AJ, Wichman CS, Phatak VS, Moore DJ, Heaton RK, Fox HS. Assessing Cognitive Functioning in People Living With HIV (PLWH): Factor Analytic Results From CHARTER and NNTC Cohorts. J Acquir Immune Defic Syndr. 2020 ;83(3):251-259.

Fields JAdam, Swinton MK, Soontornniyomkij B, Carson A, Achim CL. Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy. AIDS. 2020 ;34(7):1001-1007.

Watson CWei-Ming, Paolillo EW, Morgan EE, Umlauf A, Sundermann EE, Ellis RJ, Letendre S, Marcotte TD, Heaton RK, Grant I. Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV. J Acquir Immune Defic Syndr. 2020 ;83(1):56-64.

Robinson-Papp J, Gensler G, Navis A, Sherman S, Ellis RJ, Gelman BB, Kolson DL, Letendre SL, Singer EJ, Valdes-Sueiras M, et al. Characteristics of Motor Dysfunction in Longstanding Human Immunodeficiency Virus. Clin Infect Dis [Internet]. 2020 ;71(6):1532-1538. Available from: https://pubmed.ncbi.nlm.nih.gov/31587032/

Velasquez S, Prevedel L, Valdebenito S, Gorska AMaria, Golovko M, Khan N, Geiger J, Eugenin EA. Circulating levels of ATP is a biomarker of HIV cognitive impairment. EBioMedicine. 2020 ;51:102503.

Morgello S. Coronaviruses and the central nervous system. J Neurovirol. 2020 ;26(4):459-473.

Levine AJ, Soontornniyomkij V, Masliah E, Sinsheimer JS, Ji SS, Horvath S, Singer EJ, Kallianpur A, Moore DJ. Correction to: A candidate gene study of intermediate histopathological phenotypes in HIV-associated neurocognitive disorders. J Neurovirol. 2020 ;26(4):509-510.

Kohli M, Paolillo EW, Saloner R, Umlauf A, Ellis R, Moore DJ. The Effects of Low-Risk Drinking on Neurocognition Among Older Persons Living With HIV as Compared to Those Without HIV. Alcohol Clin Exp Res. 2020 ;44(7):1389-1399.

Gabuzda D, McArthur JC, Letendre SL. Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system. AIDS. 2020 ;34(13):1975-1977.

McNay EC, Pearson-Leary J. GluT4: A central player in hippocampal memory and brain insulin resistance. Exp Neurol. 2020 ;323:113076.

Machhi J, Kevadiya BD, Muhammad IKhan, Herskovitz J, Olson KE, R Mosley L, Gendelman HE. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Mol Neurodegener. 2020 ;15(1):32.

Sun B, Abadjian L, Monto A, Freasier H, Pulliam L. Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms. J Infect Dis. 2020 ;222(3):396-406.

Sil S, Hu G, Liao K, Niu F, Callen S, Periyasamy P, Fox HS, Buch S. HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1α/lncRNA BACE1-AS axis. PLoS Biol. 2020 ;18(5):e3000660.

Fennema-Notestine C, Thornton-Wells TA, Hulgan T, Letendre S, Ellis RJ, Franklin DR, Anderson AM, Heaton RK, Bloss CS, Grant I, et al. Iron-regulatory genes are associated with Neuroimaging measures in HIV infection. Brain Imaging Behav. 2020 ;14(5):2037-2049.

Ojeda-Juárez D, Shah R, Fields JAdam, Harahap-Carrillo IS, Koury J, Maung R, Gelman BB, Baaten BJ, Roberts AJ, Kaul M. Lipocalin-2 mediates HIV-1 induced neuronal injury and behavioral deficits by overriding CCR5-dependent protection. Brain Behav Immun. 2020 ;89:184-199.

Mukerji SS, Misra V, Lorenz DR, Chettimada S, Keller K, Letendre S, Ellis RJ, Morgello S, Parker RA, Gabuzda D. Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy. J Infect Dis. 2020 .

Martin T, Gianella S, Franklin D, Hsue P, Smith DM. Methamphetamine and cardiac disease among people with HIV infection. HIV Med. 2020 ;21(10):635-641.

Ditiatkovski M, Mukhamedova N, Dragoljevic D, Hoang A, Low H, Pushkarsky T, Fu Y, Carmichael I, Hill AF, Murphy AJ, et al. Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction. J Biol Chem. 2020 ;295(38):13377-13392.

Ellis RJ, Diaz M, Sacktor N, Marra C, Collier AC, Clifford DB, Calcutt N, Fields JA, Heaton RK, Letendre SL. Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIV. Ann Clin Transl Neurol. 2020 ;7(7):1166-1173.

Pages